Results 101 to 110 of about 28,483 (297)

Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register [PDF]

, 2017
Purpose: Beyond intravenous thrombolysis, evidence is lacking on acute treatment of minor stroke caused by large artery occlusion. To identify candidates for additional endovascular therapy, we aimed to determine the frequency of non-haemorrhagic ...
Ahmed, Niaz, Bar, Michal, Cooray, Charith, Ford, Gary A., Frol, Senta, Lees, Kennedy R., Mazya, Michael V., Moreira, Tiago, Sekaran, Lakshmanan, Toni, Danilo, Wahlgren, Nils, Švigelj, Viktor   +11 more
core   +1 more source

When Teratoma Masquerades: A Rare Case of Intrapleural Mature Cystic Teratoma Mimicking Tuberculous Empyema

Respirology Case Reports, Volume 13, Issue 6, June 2025.
We report a case of a 49‐year‐old lady with recurrent right complex pleural effusion occurring a month after completed treatment of tuberculous empyema. Imaging and diagnostic work‐up revealed a mature cystic teratoma. The rarity of intrapleural mature cystic teratoma and its misleading presentation due to the concurrent tuberculous empyema makes this ...
Nik Nuratiqah Nik Abeed, Ng Boon Hau, Nor Safiqah Sharil, Andrea Ban Yu Lin, Marfua'h Nik Ezzamudin, Hairulfaizi Haron   +5 more
wiley   +1 more source

Efficacy of argatroban plus alteplase according to time from onset to thrombolysis in acute ischemic stroke: a prespecified post-hoc analysis of the ARAIS trial

Frontiers in Neurology
BackgroundThe Argatroban Plus Recombinant Tissue-Type Plasminogen Activator for AIS (ARAIS) trial failed to demonstrate the benefit of argatroban in patients diagnosed with acute ischemic stroke who were treated with intravenous alteplase.
Yu Cui, Er-Qiang Wang, Yi-Han Wang, Hui-Sheng Chen   +3 more
doaj   +1 more source

Neuroimaging as a selection tool and endpoint in preclinical and clinical trials [PDF]

, 2016
Standard imaging in acute stroke enables the exclusion of non-stroke structural CNS lesions and cerebral haemorrhage from clinical and pre-clinical ischaemic stroke trials. In this review, the potential benefit of imaging (e.g., angiography and penumbral
Macrae, I. Mhairi, Muir, Keith W.
core   +2 more sources

Low‐Intensity Focused Ultrasound‐Responsive Nanobubbles Enhance Thrombus Targeting and Penetration for Highly Effective Thrombolytic Therapy

Small Structures, Volume 6, Issue 6, June 2025.
Low‐intensity focused ultrasound (LIFU)‐responsive nanobubbles (PAF@M) specifically target thrombus sites and penetrate thrombi under LIFU stimulation. Meanwhile, the liquid–gas phase transition of perfluoropentane and the release of nitric oxide synergistically enhance ultrasonic cavitation to destroy thrombus structure, providing a safe and effective
Wenli Zhang, Maoyuan Sun, Lian Xu, Sijin Chen, Xiyue Rong, Junrui Wang, Jia Liu, Bo Liu, Jie Xu, Ying Luo, Qianying Du, Yi Wang, Yun Liu, Zhigang Wang, Haitao Ran, Dajing Guo   +15 more
wiley   +1 more source

Predictors for cerebral edema in acute ischemic stroke treated with intravenous thrombolysis [PDF]

, 2017
Cerebral edema (CED) is a severe complication of acute ischemic stroke. There is uncertainty regarding the predictors for the development of CED after cerebral infarction.
Ahmed, Niaz, Azevedo, Elsa, Dawson, Jesse, Egido, Jose A., Falcou, Anne, Ford, Gary A., Holmin, Staffan, Mikulik, Robert, Ollikainen, Jyrki, Thorén, Magnus, Wahlgren, Nils   +10 more
core   +1 more source

The Holy Grail of cardiology?

Experimental Physiology, EarlyView.
Richard Godfrey
wiley   +1 more source

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity‐Matched Analysis From MRI‐Based Study

CNS Neuroscience &Therapeutics, Volume 31, Issue 6, June 2025.
In patients with branch atheromatous disease‐related stroke, argatroban was not associated with excellent outcome (mRS 0–1) at 90 days, though it was widely used. The risks and benefits of argatroban need reevaluation in this patient population. ABSTRACT Background and Purpose Argatroban is widely used for patients with acute branch atheromatous ...
Shengde Li, Haizhou Hu, Yaping Zhou, Ping Zhang, Guofang Chen, Hongying Bai, Bin Liu, Lixin Zhou, Yicheng Zhu, Bin Peng, Jun Ni, on behalf of BAD‐study investigators   +11 more
wiley   +1 more source

Using alteplase nephrostomy tube installation for thrombolysis of ureter tract clot obstruction

Urology Case Reports, 2021
In literature, few cases have been reported regarding the use of alteplase installation in a nephrostomy as anticoagulant treatment of blood clots in the upper urinary tract.Our case -report provides a unique case of alteplase installation in the ...
Paoyan Lin, Tomasz Fiutowski, Christoph Ansorge   +2 more
doaj  

Eficacia y seguridad del tenecteplase en el tratamiento del ACV isquémico agudo

Acta Neurológica Colombiana, 2020
El alteplase es el único fibrinolítico actualmente autorizado en Colombia para el tratamiento del ACV isquémico agudo. El tenecteplase constituye una nueva alternativa de tratamiento en esta enfermedad al ofrecer mejor perfil farmacológico, mayor ...
Javier Francisco Torres Zafra, Germán Enrique Pérrez Romero   +1 more
doaj   +1 more source